It was found that hepatic Lpl mRNA expression was higher in obese patients than normal controls [33] and reducing hepatic LPL activity was effective in ameliorating diet-induced obesity and hepatic steatosis [34]. Here, LPL is linked to obesity due to melanocortin 4 receptor deficiency.